CPH creso pharma limited

SPP, page-8

  1. 11,676 Posts.
    lightbulb Created with Sketch. 473
    Also for a company that only has a market cap between 80-100mln to undertake a 20-25% CR is very ambitious at such an early stage of the MC industry. This may end up being a 50/50 chance of success or failure if revenue streams can't be locked in, and that's why the market is underwhelmed. Risky business now.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.